Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine vs Regular Insulin in Acute Stroke (ICAS)
NCT02607943Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Dec 2015
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in hyperglycemia, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
insulin glargine
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT02607943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607943.